Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
---|---|---|---|---|
Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
Börsenplätze | Performance | Management | Volatilität | Watchlist |
Historisch | Benchmark | Sharpe Ratio | ||
Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
11.00 GBP | -0.07 GBP | -0.63 % |
---|
Vortag | 11.07 GBP | Datum | 12.12.2024 |
Anzeige
Name | ISIN | Performance | |
---|---|---|---|
21Shares Sui Staking ETP | CH1360612159 | 431.58% | |
21Shares Stellar ETP | CH1109575535 | 362.55% | |
21Shares Ripple XRP ETP | CH0454664043 | 328.80% | |
21Shares Algorand ETP | CH1146882316 | 238.12% | |
21Shares Stacks Staking ETP | CH1258969042 | 227.84% | |
21Shares Cardano ETP | CH1102728750 | 217.69% | |
21Shares Injective Staking ETP | CH1360612134 | 56.67% | |
21Shares Immutable ETP | CH1360612142 | 54.85% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Ripple XRP ETP | CH0454664043 | 380.65% | |
21Shares Stellar ETP | CH1109575535 | 326.01% | |
21Shares Aave ETP | CH1135202120 | 294.24% | |
21Shares Cardano ETP | CH1102728750 | 154.54% | |
21Shares Algorand ETP | CH1146882316 | 153.23% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Aave ETP | CH1135202120 | 290.47% | |
21Shares Ripple XRP ETP | CH0454664043 | 282.32% | |
21Shares Solana staking ETP | CH1114873776 | 245.30% | |
21Shares Stellar ETP | CH1109575535 | 244.99% | |
21Shares Fantom ETP | CH1168929078 | 217.01% |
Name | ISIN | Performance | |
---|---|---|---|
21Shares Solana staking ETP | CH1114873776 | 1’730.28% | |
21Shares Ripple XRP ETP | CH0454664043 | 513.99% | |
21Shares Bitcoin Core ETP | CH1199067674 | 496.19% | |
21Shares Aave ETP | CH1135202120 | 495.86% | |
21Shares Bitcoin ETP | CH0454664001 | 481.11% |
Fundamentaldaten
Valor | 125957293 |
ISIN | LU2596924402 |
Emittent | T. Rowe Price Management |
Aufgelegt in | Luxembourg |
Auflagedatum | 05.04.2023 |
Kategorie | Branchen: Gesundheitswesen |
Währung | GBP |
Volumen | 232’566’430.66 |
Depotbank | J.P. Morgan SE, Luxembourg Branch |
Geschäftsjahresende | 31.12. |
Berichtsstand | 11.12.2024 |
Anlagepolitik
So investiert der Select Investment Series III SICAV - T. Rowe Price Health Sciences Equity Fund ID Fonds: To increase the value of its shares, over the long term, through growth in the value of, and income from, its investments. The fund is actively managed and invests mainly in a diversified portfolio of shares of companies that are involved in the research, development, production, or distribution of products or services related to health sciences. The companies may be anywhere in the world, including emerging markets, with a focus on companies in the United States.
ETP Performance: Select Investment Series III SICAV - T. Rowe Price Health Sciences Equity Fund ID Fonds
Performance 1 Jahr | 10.78 | |
Performance 2 Jahre | - | |
Performance 3 Jahre | - | |
Performance 5 Jahre | - | |
Performance 10 Jahre | - |